Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ralph Corey

Showing results (71-80 of 157) with videos related to

Pageof 16
Sort By:
International Journal of Antimicrobial Agents|February 5, 2019
Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trialsG Ralph Corey, Mark H Wilcox, Jesus Gonzalez, et al.
Diagnostic Microbiology and Infectious Disease|November 7, 2017
The effect of pulmonary surfactant on the in vitro activity of Iclaprim against common respiratory bacterial pathogensDavid B Huang, Leonard R Duncan, Robert K Flamm, et al.
American Heart Journal|May 17, 2011
Chronic noncommunicable cardiovascular and pulmonary disease in sub-Saharan Africa: an academic model for countering the epidemicGerald S Bloomfield, Sylvester Kimaiyo, E Jane Carter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2010
Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infectionG Ralph Corey, Mark Wilcox, George H Talbot, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2009
Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failureEsteban C Nannini, Martin E Stryjewski, Kavindra V Singh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2011
A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infectionsJ Carl Craft, Susan R Moriarty, Kay Clark, et al.
Diagnostic Microbiology and Infectious Disease|September 30, 2018
Surveillance of iclaprim activity: in vitro susceptibility of Gram-positive skin infection pathogens collected from 2015 to 2016 from North America and EuropeDavid B Huang, Sophie Magnet, Stefania De Angelis, et al.
The Journal of Infection|October 19, 2005
A meta-analysis of medical versus surgical therapy for Candida endocarditisWilliam J Steinbach, John R Perfect, Christopher H Cabell, et al.
Cardiology in Review|April 14, 2004
An intracardiac mass in a young man with congenitally acquired HIVManesh R Patel, Louise E J Thomson, Trip J Meine, et al.
Circulation|March 24, 2004
Early predictors of in-hospital death in infective endocarditisVivian H Chu, Christopher H Cabell, Daniel K Benjamin, et al.
Pageof 16

Showing results (71-80 of 157) with videos related to

Sort By:
Pageof 16
International Journal of Antimicrobial Agents|February 5, 2019
Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trialsG Ralph Corey, Mark H Wilcox, Jesus Gonzalez, et al.
Diagnostic Microbiology and Infectious Disease|November 7, 2017
The effect of pulmonary surfactant on the in vitro activity of Iclaprim against common respiratory bacterial pathogensDavid B Huang, Leonard R Duncan, Robert K Flamm, et al.
American Heart Journal|May 17, 2011
Chronic noncommunicable cardiovascular and pulmonary disease in sub-Saharan Africa: an academic model for countering the epidemicGerald S Bloomfield, Sylvester Kimaiyo, E Jane Carter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2010
Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infectionG Ralph Corey, Mark Wilcox, George H Talbot, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2009
Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failureEsteban C Nannini, Martin E Stryjewski, Kavindra V Singh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2011
A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infectionsJ Carl Craft, Susan R Moriarty, Kay Clark, et al.
Diagnostic Microbiology and Infectious Disease|September 30, 2018
Surveillance of iclaprim activity: in vitro susceptibility of Gram-positive skin infection pathogens collected from 2015 to 2016 from North America and EuropeDavid B Huang, Sophie Magnet, Stefania De Angelis, et al.
The Journal of Infection|October 19, 2005
A meta-analysis of medical versus surgical therapy for Candida endocarditisWilliam J Steinbach, John R Perfect, Christopher H Cabell, et al.
Cardiology in Review|April 14, 2004
An intracardiac mass in a young man with congenitally acquired HIVManesh R Patel, Louise E J Thomson, Trip J Meine, et al.
Circulation|March 24, 2004
Early predictors of in-hospital death in infective endocarditisVivian H Chu, Christopher H Cabell, Daniel K Benjamin, et al.
Pageof 16